Post by Antoine de Saint-Affrique

Full year results are in, and we delivered at Danone another year of broad‑based, quality growth, reaffirming the strength and resilience of our health‑focused portfolio. All categories and geographies contributed, with strong momentum in China, North Asia & Oceania, and sustained progress in Europe. We continued to perform while transforming the company and reinvesting in capabilities, science and innovation. As we advance Chapter 2 of Renew Danone, we are reshaping our portfolio: scaling U.S. Medical Nutrition, strengthening our dairy strongholds, advancing microbiome science, and accelerating digitalisation. Yet we remain clear-eyed: there is more to do and some areas still require fixing. Looking ahead to 2026, we remain disciplined and fully committed to our science-based and consumer and patient centric approach. A heartfelt thank you to all Danoners for your commitment and passion! #RENEWDANONE Juergen Esser

Video Content